The yield and clinical impact of genetic testing in older patients with dilated cardiomyopathy.

doi:10.1093/ejhf/xuag055

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

The yield and clinical impact of genetic testing in older patients with dilated cardiomyopathy.

European journal of heart failure - 15 Sept 2026

Cannie Douglas E, Bakalakos Athanasios, Syrris Petros, Protonotarios Alexandros, Lorenzini Massimiliano, Guttmann Oliver, O'Mahony Constantinos, Savvatis Konstantinos, Sekhri Neha, Mohiddin Saidi, Lopes Luis R, Elliott Perry M

Abstract excerpt

AIMS: Genetic testing in patients with dilated cardiomyopathy (DCM) is increasingly used to guide clinical management, but international guidance does not endorse genetic testing for older patients. This study sought to explore the yield and impact of genetic testing in older patients with DCM. METHODS: Consecutive and unrelated genotyped patients with DCM were retrospectively recruited in a single referral...

Read the complete abstract on PubMed

Topics

Humans
Cardiomyopathy, Dilated
Genetic Testing
Female
Middle Aged

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Male

Retrospective Studies

Genotype

Adult

Age Factors

Aged

Genetic Predisposition to Disease

Heart Failure

Follow-Up Studies

Source

Open in PubMed

Identifiers

PMID: 41777186
DOI: 10.1093/ejhf/xuag055

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The yield and clinical impact of genetic testing in older patients with dilated cardiomyopathy.PMID 41777186Read ↗

Implications of Genetic Testing in Dilated Cardiomyopathy.Semantic proximity Read ↗

The Genetic Evaluation of Dilated CardiomyopathySemantic proximity Read ↗

Hypertrophic Cardiomyopathy: The Impact of Age at Diagnosis of the Proband on Genetic Yield, Clinical Presentation, Outcomes, and Yield of Family Screening.Semantic proximity Read ↗

Association of Titin Variations With Late-Onset Dilated Cardiomyopathy.Semantic proximity Read ↗

Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy.Semantic proximity Read ↗

Genetic testing in cardiomyopathies: do we need to redefine the UK national testing criteria?Semantic proximity Read ↗

Diagnostic yield of genetic testing in a multinational heterogeneous cohort of 2088 DCM patientsSemantic proximity Read ↗

The clinical impact of genetic testing in comprehensive cardiomyopathies.Semantic proximity Read ↗

Hypertrophic Cardiomyopathy – The Impact of Age at Diagnosis of the Proband on Genetic Yield, Clinical Presentation, Outcomes, and Yield of Family ScreeningSemantic proximity Read ↗

Predicted Deleterious Variants in Cardiomyopathy Genes Prognosticate Mortality and Composite Outcomes in the UK Biobank.Semantic proximity Read ↗

The Rationale and Timing of Molecular Genetic Testing for Dilated Cardiomyopathy.Semantic proximity Read ↗

Genotype-phenotype Correlations of Hypertrophic Cardiomyopathy When Diagnosed in Children, Adolescents, and Young Adults.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.